The University of Southampton
University of Southampton Institutional Repository

Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice

Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice
Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice
Myelin oligodendrocyte glycoprotein (MOG) is a powerful encephalitogen for experimental autoimmune demyelination. However, the use of MOG peptides or recombinant proteins representing part of the protein fails to fully address the possible pathogenic role of the full-length myelin-derived protein expressing post-translational modifications. Immunization of mice with central nervous system tissues from wild-type (WT) and MOG-deficient (MOG–/–) mice demonstrates that MOG in myelin is necessary for the development of chronic demyelinating experimental autoimmune encephalomyelitis (EAE) in mice. While immunization with WT spinal cord homogenate (SCH) resulted in a progressive EAE phenotype, MOG–/– SCH induced a mild self-limiting acute disease. Following acute EAE with MOG–/– SCH, mice developed T cell responses to recombinant mouse MOG (rmMOG), indicating that MOG released from myelin is antigenic; however, the lack of chronic disease indicates that such responses were not pathogenic. Chronic demyelinating EAE was observed when MOG–/– SCH was reconstituted with a dose of rmMOG comparable to MOG in myelin (2.5% of total white matter-derived protein). These data reveal that while immunization with the full-length post-translational modified form of MOG in myelin promotes the development of a more chronic autoimmune demyelinating neurological disease, MOG (and/or other myelin proteins) released from myelin during ongoing disease do not induce destructive autoimmunity.
0014-2980
Smith, P.A.
d330ca6e-c6fe-490b-a1ec-04cd6bc7fc75
Heijmans, N.
811b40ea-dc48-40ab-99b1-a99765c91bf3
Ouwerling, B.
c3573647-66c5-40ae-9c35-f821ae050050
Breij, E.C.
064ace2d-a0a5-4ced-93dd-823f3b4f3152
Evans, N.
06a05c97-bfed-4abb-9244-34ec9f4b4b95
van Noort, J.M.
9f6b92b6-a3c0-48ac-8b21-9c41aad9bcb6
Plomp, A.C.
ca2f349b-6783-4a6c-92b2-5c3f5490a7f8
Delarasse, C.
c43e77f8-bfd8-4958-add5-684e517d6430
Hart, B.
8338a884-c147-4ff0-9879-ca8b6959c901
Pham-Dinh, D.
095c194c-0951-407f-9337-01de30753465
Amor, S.
2dbbad22-f45f-47bc-b33a-e9ebcdb057ce
Smith, P.A.
d330ca6e-c6fe-490b-a1ec-04cd6bc7fc75
Heijmans, N.
811b40ea-dc48-40ab-99b1-a99765c91bf3
Ouwerling, B.
c3573647-66c5-40ae-9c35-f821ae050050
Breij, E.C.
064ace2d-a0a5-4ced-93dd-823f3b4f3152
Evans, N.
06a05c97-bfed-4abb-9244-34ec9f4b4b95
van Noort, J.M.
9f6b92b6-a3c0-48ac-8b21-9c41aad9bcb6
Plomp, A.C.
ca2f349b-6783-4a6c-92b2-5c3f5490a7f8
Delarasse, C.
c43e77f8-bfd8-4958-add5-684e517d6430
Hart, B.
8338a884-c147-4ff0-9879-ca8b6959c901
Pham-Dinh, D.
095c194c-0951-407f-9337-01de30753465
Amor, S.
2dbbad22-f45f-47bc-b33a-e9ebcdb057ce

Smith, P.A., Heijmans, N., Ouwerling, B., Breij, E.C., Evans, N., van Noort, J.M., Plomp, A.C., Delarasse, C., Hart, B., Pham-Dinh, D. and Amor, S. (2005) Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice. European Journal of Immunology. (doi:10.1002/eji.200425842).

Record type: Article

Abstract

Myelin oligodendrocyte glycoprotein (MOG) is a powerful encephalitogen for experimental autoimmune demyelination. However, the use of MOG peptides or recombinant proteins representing part of the protein fails to fully address the possible pathogenic role of the full-length myelin-derived protein expressing post-translational modifications. Immunization of mice with central nervous system tissues from wild-type (WT) and MOG-deficient (MOG–/–) mice demonstrates that MOG in myelin is necessary for the development of chronic demyelinating experimental autoimmune encephalomyelitis (EAE) in mice. While immunization with WT spinal cord homogenate (SCH) resulted in a progressive EAE phenotype, MOG–/– SCH induced a mild self-limiting acute disease. Following acute EAE with MOG–/– SCH, mice developed T cell responses to recombinant mouse MOG (rmMOG), indicating that MOG released from myelin is antigenic; however, the lack of chronic disease indicates that such responses were not pathogenic. Chronic demyelinating EAE was observed when MOG–/– SCH was reconstituted with a dose of rmMOG comparable to MOG in myelin (2.5% of total white matter-derived protein). These data reveal that while immunization with the full-length post-translational modified form of MOG in myelin promotes the development of a more chronic autoimmune demyelinating neurological disease, MOG (and/or other myelin proteins) released from myelin during ongoing disease do not induce destructive autoimmunity.

This record has no associated files available for download.

More information

Published date: 22 March 2005

Identifiers

Local EPrints ID: 471296
URI: http://eprints.soton.ac.uk/id/eprint/471296
ISSN: 0014-2980
PURE UUID: 10180899-fe65-40e6-91ca-e66f546717ec
ORCID for N. Evans: ORCID iD orcid.org/0000-0002-3255-4388

Catalogue record

Date deposited: 02 Nov 2022 17:40
Last modified: 17 Mar 2024 03:22

Export record

Altmetrics

Contributors

Author: P.A. Smith
Author: N. Heijmans
Author: B. Ouwerling
Author: E.C. Breij
Author: N. Evans ORCID iD
Author: J.M. van Noort
Author: A.C. Plomp
Author: C. Delarasse
Author: B. Hart
Author: D. Pham-Dinh
Author: S. Amor

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×